Alagille Syndrome - 13 Studies Found Completed : Positional Cloning of the Gene(s) Responsible for Alagille Syndrome : Alagille Syndrome : 2000-04-06 Recruiting : Characterization of Pulmonary Artery Stenoses in Alagille Syndrome - a Medical Record Review : Alagille Syndrome : 2012-01-18 Completed : Evaluation of LUM001 in the Reduction of Pruritus in Alagille Syndrome : Alagille Syndrome : 2014-02-05 : Drug: LUM001 LUM001 administer Active, not recruiting : A Long-Term, Open-Label Study of LUM001 With a Double-Blind, Placebo Controlled, Randomized Drug Withdrawal Period to Evaluate Safety and Efficacy in Children With Alagille Syndrome : Alagille Syndrome : 2014-06-09 : Drug: LUM001 LUM001 administer Completed : Safety and Efficacy Study of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Alagille Syndrome : Alagille Syndrome : 2013-07-16 : Drug: LUM001 Drug: Placebo Active, not recruiting : An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Subjects With Alagille Syndrome (ALGS) : Alagille Syndrome : 2014-01-23 : Drug: LUM001 Dosing of LUM001 with the objective of achieving optimal control of pruritus at a dose leve Active, not recruiting : An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome : Alagille Syndrome : 2014-04-16 : Drug: LUM001 Administered orally daily Completed : Validation of the Itch Reported Outcome (ItchRO) Diaries in Pediatric Cholestatic Liver Disease : Alagille Syndrome Progressive Familial Intrahepatic Cholestasis : 2014-05-01 Completed : Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease : Alagille Syndrome Cholestasis : 2000-12-06 : Drug: magnesium gluconate Drug: magnesium Recruiting : Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC) : Liver Diseases Alagille Syndrome